SCHEMBL29655183

SCHEMBL29655183

Cc1ccccc1C1OCC(O)CO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.41
HTR2C P28335 3/20 0.40
HTR2A P28223 1/20 0.40
HTR2B P41595 1/20 0.40
ALDH1A1 P00352 4/20 0.37
GLA P06280 1/20 0.37
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
MAPT P10636 3/20 0.34
HPGD P15428 1/20 0.34
USP2 O75604 1/20 0.34
THRB P10828 1/20 0.34
DDB1 Q16531 1/20 0.33
CRBN Q96SW2 1/20 0.33
TSHR P16473 1/20 0.33
ACHE P22303 1/20 0.33
OPRL1 P41146 1/20 0.33
KCNH2 Q12809 1/20 0.33
P2RX7 Q99572 1/20 0.33
MAOA P21397 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6590588 0.79 HTR2C (0.44) TAAR1HTR2CHTR2AHTR2BALDH1A1
SCHEMBL11635434 0.77 KMT2A (0.44) TAAR1HTR2CHTR2AHTR2BMEN1
SCHEMBL11632118 0.77 HTR2C (0.41) HTR2CHTR2AHTR2BMEN1KMT2A
SCHEMBL11632004 0.77 KDM1A (0.41) HTR2CHTR2BMEN1KMT2AMAOA
SCHEMBL11629567 0.77 HTR2C (0.44) HTR2CHTR2AHTR2BMEN1KMT2A
SCHEMBL3083610 0.76 HTR2C (0.42) TAAR1HTR2CHTR2AHTR2BALDH1A1
SCHEMBL11635724 0.73 HTR2A (0.49) HTR2CHTR2AHTR2BALDH1A1GLA
SCHEMBL8524358 0.73 TAAR1 (0.52) TAAR1HTR2CHTR2AHTR2BALDH1A1
SCHEMBL168917 0.73 TAAR1 (0.52) TAAR1HTR2CHTR2AHTR2BALDH1A1
SCHEMBL8525267 0.73 TAAR1 (0.52) TAAR1HTR2CHTR2AHTR2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240277012-A1 DUPLICATE BEVERAGE WANG JIE (US) 2024-08-22 US disclosed
US-20240108040-A1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2024-04-04 US disclosed
US-11758933-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2023-09-19 US disclosed
EP-3368542-B1 HIGH INTENSITY SWEETENERS FIRMENICH INCORPORATED (US) 2022-06-22 EP disclosed
US-11357246-B2 High intensity sweeteners FIRMENICH INCORPORATED (US) 2022-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108040-A1 HIGH INTENSITY SWEETENERS TAS2R40, TAS2R60, TAS1R1 TAAR1 942/4885HTR2C 3556/4885HTR2A 2850/4885
US-11357246-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 TAAR1 942/4885HTR2C 3556/4885HTR2A 2850/4885
US-11758933-B2 High intensity sweeteners TAS2R40, TAS2R60, TAS1R1 TAAR1 942/4885HTR2C 3556/4885HTR2A 2850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.